Balanced news tone
News Sentiment
PME sentiment intelligence
Pro Medicus Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
56
Balanced news tone
32 relevant articles
Price is moving more forcefully than the current news tone suggests.
90/100 classification confidence.
directly relevant articles
high-authority source matches
+5.4% over one week, +35.1% over four weeks, trend inactive, and near fair-value range.
Pro Medicus (ASX:PME) gains after leaving ASX 50, mid-cap ETF demand seen
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
90/100 classification
One-week reaction
5.4%
Price confirming higher
Trend fit
Trend inactive
35.1% over four weeks
Fair value
-0.8%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
10
Neutral
22
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Bez Kabli
Direct company coverage
Pro Medicus (ASX:PME) gains after leaving ASX 50, mid-cap ETF demand seen
- Tone
- Positive 66/100
- Event
- Macro sensitivity
- Published
- 22 Jun 2026 20:57
- Source
- Bez Kabli
simplywall.st
Direct company coverage
Pro Medicus (ASX:PME) Shares Could Be 11.3% Undervalued After Index Exit And US Wins
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 08:28
- Source
- simplywall.st
Kalkine Media
Direct company coverage
Is Pro Medicus (ASX:PME) a Strong Buy Signal for ASX Health-Tech?
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 22 Jun 2026 07:50
- Source
- Kalkine Media
marketscreener.com
Direct company coverage
Pro Medicus Limited(ASX: PME) dropped from S&P Global 1200
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 01:01
- Source
- marketscreener.com
marketscreener.com
Direct company coverage
Pro Medicus Limited(ASX: PME) dropped from S&P/ASX 50 Index
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 00:42
- Source
- marketscreener.com
Kalkine Media
Direct company coverage
Pro Medicus (ASX:PME): Why This Global Healthcare Leader Is Drawing Fresh Attention
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 00:20
- Source
- Kalkine Media
AD HOC NEWS
Direct company coverage
Pro Medicus Stock - Long-term strategy and AI imaging ambitions
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jun 2026 17:16
- Source
- AD HOC NEWS
Kalkine
Direct company coverage
Is Pro Medicus (ASX:PME) Worth Adding to Your Watchlist?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 10:13
- Source
- Kalkine
Kalkine Media
Direct company coverage
Why Pro Medicus (ASX:PME) Is Leading the Growth Stock Conversation
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 19 Jun 2026 10:12
- Source
- Kalkine Media
simplywall.st
Direct company coverage
Pro Medicus (ASX:PME) Shares Valuation After S&P/ASX 50 Removal And Recent Contract Renewals
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 13 Jun 2026 18:34
- Source
- simplywall.st
The Motley Fool Australia
Direct company coverage
Is it time to get greedy with Pro Medicus shares?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- The Motley Fool Australia
simplywall.st
Direct company coverage
Should Visage 7 AI‑Optimized Reporting Rollout Shape Pro Medicus’ (ASX:PME) Long‑Term Imaging Edge?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- simplywall.st
The Motley Fool Australia
Direct company coverage
Why might Pro Medicus shares soon be under pressure?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- The Motley Fool Australia
Morningstar
Direct company coverage
Pro Medicus Shares Remain Overvalued, While Transferring Coverage
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Morningstar
TradingView
Direct company coverage
PME, TNE, WTC, XRO, is it finally time to buy ASX tech stocks? Plus, base metals prices are soaring while lithium is teetering
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Jun 2026 23:30
- Source
- TradingView
The Motley Fool Australia
Direct company coverage
Why AI is making Pro Medicus shares a once-in-a-generation buy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- The Motley Fool Australia
The Motley Fool Australia
Direct company coverage
Why are Pro Medicus shares rocketing 12% today?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- The Motley Fool Australia
Kalkine
Direct company coverage
Why Is Pro Medicus (ASX:PME) Stock Up Today?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Kalkine
Kalkine
Direct company coverage
Pro Medicus (ASX:PME) Falls as Investors Rotate Out of Healthcare Growth Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- Kalkine
The Motley Fool Australia
Direct company coverage
Down 40% but not out: Is Pro Medicus the buy of the decade right now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- The Motley Fool Australia
The Motley Fool Australia
Direct company coverage
What on earth’s going on with Pro Medicus shares?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- The Motley Fool Australia
Market source
Direct company coverage
Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Apr 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Pro Medicus (ASX:PME) Net Margin Near 100% Reinforces Bullish Profitability Narratives
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 13 Feb 2026 08:00
- Source
- simplywall.st
Market source
Direct company coverage
Capital Investment Trends At Pro Medicus (ASX:PME) Look Strong
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Feb 2026 08:00
- Source
- Market source
ig.com
Direct company coverage
Stock of the day: Pro Medicus
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Feb 2026 08:00
- Source
- ig.com
Livewire Markets
Direct company coverage
Debt-free and still delivering: Why WAM is backing Pro Medicus despite big sell-off
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Feb 2026 08:00
- Source
- Livewire Markets
Market source
Direct company coverage
Pro Medicus (ASX:PME) sheds 3.5% this week, as yearly returns fall more in line with earnings growth
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jan 2026 08:00
- Source
- Market source
intelligentinvestor.com.au
Direct company coverage
Pro Medicus: The case to dip your toe
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jan 2026 08:00
- Source
- intelligentinvestor.com.au
simplywall.st
Direct company coverage
The total return for Pro Medicus (ASX:PME) investors has risen faster than earnings growth over the last five years
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 05 Jan 2026 08:00
- Source
- simplywall.st
Market source
Direct company coverage
With 49% ownership, insiders at Pro Medicus Limited (ASX:PME) are pretty optimistic and have been buying recently
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Dec 2025 08:00
- Source
- Market source